Substances · Phenethylamine derivatives
6-APB
- Preferred name
- 6-APB
- IUPAC name
- 1-(1-benzofuran-6-yl)propan-2-amine
- Parent CAS number (reference)
- 286834-85-3
- Molecular formula
- C11H13NO
- Molecular weight
- 175.23 g/mol
- InChIKey
- FQDAMYLMQQKPRX-UHFFFAOYSA-N
- PubChem
- CID 9794343
- Source
- PubChem
- Verified synonyms & catalog abbreviations
-
6-(2-Aminopropyl)benzofuran Benzofury 6APB 6 APB
Matching Listings in This Store's Catalog
Verified Neurochemical & Toxicological Intelligence
6-APB (Benzofury)
Receptor Telemetry & Mechanism of Action
6-APB is a 6-benzofuran amphetamine analogue and a monoamine releaser with a more psychedelic edge than MDMA or 5-MAPB. It is also an agonist at 5-HT2B. That receptor is the valvular-heart concern shared with fenfluramine and other chronic 5-HT2B agonists, so frequent repeated use is a different risk from a single spaced exposure. The primary amine lasts longer than N-methyl 5-MAPB.
Biotransformation & Active Metabolites
Not a prodrug of MDA. Succinate is a common salt and is heavier than the freebase (C11H13NO, 175.23 g/mol) or the hydrochloride. PsychonautWiki oral bands should not be copied blindly from one salt onto another. 6-MAPB is the N-methyl analogue and has its own, lower TripSit oral band.
Temporal Pharmacokinetics
Long entactogen with a psychedelic tint, more stimulation early and a heavy, warm body later. Less 'clean' than 5-MAPB and much longer.
- Onset 30–60 minutes
- Peak Window 3–4 hours
- Total Window 7–10 hours
- Residual / Half-Life After-effects 6–48 hours. PsychonautWiki lists tolerance returning toward baseline only after several weeks for this compound.
Threshold 15 mg, light 30–60 mg, common 60–90 mg, strong 90–120 mg, heavy above 120 mg. Come-up is 60–120 minutes. That slow rise is the entire redose problem: a second dose at one hour arrives during a 3–4 hour peak and a 7–10 hour total course.
Quantitative Response Spectrum (Published Literature)
Third-person observational & toxicological brackets reported in scientific and harm-reduction literature — reference telemetry only, never consumption advice.
15 mg
A mild mood and body shift.
Little more than a warm flush.
30–60 mg
Soft empathy, light visuals, and stimulation that has not peaked.
Nausea, jaw tension, and a rising heart rate.
60–90 mg
Full entactogenic and mildly psychedelic effects, music enhancement, and emotional openness over many hours.
Bruxism, sweating, dilated pupils, vasoconstriction, and a sustained cardiovascular load.
90–120 mg
Intense visuals for a benzofuran, overwhelming empathy or anxiety, and a very long course.
Hyperthermia risk, vomiting, and marked blood-pressure elevation.
120 mg+
A toxic, confused entactogenic state. More material does not fix a come-up that was simply slow.
Severe hyperthermia, serotonin toxicity if combined with another releaser, and seizures with tramadol.
Interaction Matrix & Critical Contraindications
Critical Hazard — Never Combine
Blocking monoamine breakdown while a releaser or a catecholamine uptake inhibitor is active can produce a hypertensive crisis and, for the serotonergic members, serotonin toxicity.
A second releaser on top of a 7–10 hour serotonin releaser is a hyperthermia and serotonin-toxicity combination.
Both lower the seizure threshold. Tramadol also adds serotonin reuptake inhibition, which is dangerous with the serotonergic releasers in this set.
Elevated Hazard — Avoid
6-APB already lasts most of a day. Added stimulants, NBOMes, and heat raise hyperthermia, vasoconstriction, and seizure risk.
Worsens dehydration and judgment across a very long course.
Caution / Receptor Attenuation
Blunt the entactogenic phase unevenly. Not a safety factor.
Chronic 5-HT2B agonism is the valvular-heart concern. Spacing is part of the risk profile, not only the comedown.
Structural Isomer & Sibling Comparison
6-APB is the long primary-amine benzofuran: common 60–90 mg, come-up 1–2 hours, total 7–10 hours, more psychedelic than 5-MAPB. 5-MAPB common is 60–80 mg over 5–8 hours and warmer. 6-MAPB, the N-methyl sibling, is placed by TripSit at a common oral 40–80 mg and is generally described as smoother and less stimulating. All three forbid stacked releasers. Salt mass (succinate versus hydrochloride) moves the real amount inside every one of these bands.
Physicochemical Stability & Storage
Form: White, off-white, or pale tan crystalline powder, shards, or clumps as the hydrochloride or another salt. Not a plant blend. · Hydrochloride salts dissolve in water and alcohols. Succinate salts of the benzofurans also dissolve in water but contain less active amine per milligram.
Airtight, cool, dry, and dark. Some salts are hygroscopic and clump. A clump is not a reason to guess the mass.
Cross-Tolerance & Dependence Profile
PsychonautWiki lists full tolerance with repeated use, a half-reduction on the order of 3–4 weeks, and a return toward baseline around 6–8 weeks, with cross-tolerance to dopaminergic stimulants and, in practice, to other entactogens. That is a longer reset than a weekend stimulant. The crash is serotonergic. Urge to redose during the slow come-up is behavioral, and it is how heavy amounts happen.
Chemical Architecture & Structural Profile
6-APB (1-(1-benzofuran-6-yl)propan-2-amine) is a reference compound belonging to the Phenethylamine derivatives class, characterized by the molecular formula C11H13NO and a molar mass of 175.23 g/mol. The parent molecule is indexed under CAS registry number 286834-85-3 and in the NCBI PubChem database as CID 9794343 (Standard InChIKey: FQDAMYLMQQKPRX-UHFFFAOYSA-N).
Citations
- PubChem — PubChem (2026-11-12)
Reference Toxicology & Safety Profile
In documented chemical and harm-reduction literature (PubChem / PsychonautWiki, CC BY 4.0), 6-APB is indexed within the Substituted amphetamines, Substituted benzofurans structural group. Toxicological notes (PsychonautWiki): exact toxic threshold is unknown. Dependence liability (PsychonautWiki): moderately addictive with a high potential for abuse. Documented cross-tolerance class: dopamine, stimulant. Standard laboratory handling precautions—including nitrile gloves, eye protection, and local exhaust ventilation—apply whenever handling the reference material.
Citations
- PubChem — PubChem (2026-11-12)
Analytical Use & Laboratory Notice
This reference sheet provides chemical, analytical, and toxicological provenance only. The material is strictly not for human consumption, diagnostic, or veterinary use. Research-use labelling does not establish legal status in any jurisdiction.
Citations
- EUDA / National Chemical & Controlled Substance Registry (IE) — National Regulatory Authority (IE) (2026-11-12)